Biorchestra Wins Grand Prize in 2023 Merck Advance Biotech Grant Program
17 Jul 2023 //
PR NEWSWIRE
BIORCHESTRA Invited to Present Update on Central Nervous System Lead Program
01 Jun 2023 //
PR NEWSWIRE
Biorchestra Scientific Founder, Chairman, And Ceo Joins The (Rok)
25 Apr 2023 //
PR NEWSWIRE
Biorchestra Announces Significant Progress in Studies of BMD-001 Drug Program
24 Apr 2023 //
PR NEWSWIRE
Biorchestra Appoints David Oxley as Chief Business Officer
05 Apr 2023 //
PR NEWSWIRE
BIORCHESTRA announces that BMD-001 reduces Amyloid-? & Tau in non-human primate
08 Nov 2022 //
PRNEWSWIRE
BIORCHESTRA`s BMD-001 for AD and drug delivery system technology at 2022 BIO
09 Jun 2022 //
PRNEWSWIRE
BIORCHESTRA Participated in Formulation and Delivery
12 May 2022 //
PRNEWSWIRE
BIORCHESTRA Announces 45 Million USD Series C Fundraising
22 Feb 2022 //
PRNEWSWIRE